You are here

Flu

GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine

GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine

Clinical Trials Arena

Flag link:

Zenshine’s Phase ll influenza therapy trial meets primary endpoint

Zenshine’s Phase ll influenza therapy trial meets primary endpoint

Clinical Trials Arena

clinical trials

Flag link:

Novavax Presents COVID-19 Booster and Flu Combo Vaccine Studies

Novavax Presents COVID-19 Booster and Flu Combo Vaccine Studies

BioSpace

Flag link:

FDA issues rare comment on approval of Covid and flu home test from company that went bankrupt

FDA issues rare comment on approval of Covid and flu home test from company that went bankrupt

Stat

Flag link:

Lucira Gets FDA Authorization for First OTC At-Home Test for COVID-19 and Flu

Lucira Gets FDA Authorization for First OTC At-Home Test for COVID-19 and Flu

Xtalks

Flag link:

The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy

The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy

Stat

Flag link:

Where Will Moderna Be in 5 Years?

Where Will Moderna Be in 5 Years?

Motley Fool

Moderna Therapeutics

Flag link:

Moderna checks a few boxes in phase 3 mRNA flu shot trial, but misses on B strains and safety

Moderna checks a few boxes in phase 3 mRNA flu shot trial, but misses on B strains and safety

Fierce Biotech

Moderna Therapeutics

clinical trials

Flag link:

mRNA vaccines: Four major clinical trial readouts to watch in 2023

mRNA vaccines: Four major clinical trial readouts to watch in 2023

Clinical Trials Arena

clinical trials

Moderna Therapeutics

Flag link:

After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults

After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults

Fierce Biotech

clinical trials

Flag link:

Novavax begins Phase II study for Covid-19-Influenza vaccines

Novavax begins Phase II study for Covid-19-Influenza vaccines

Clinical Trials Arena

clinical trials

Flag link:

Several manufacturers report Tamiflu shortage as flu season reaches high point

Several manufacturers report Tamiflu shortage as flu season reaches high point

Endpoints

Flag link:

Vaxess' flu vaccine patch passes early clinical test, clearing path for further development

Vaxess' flu vaccine patch passes early clinical test, clearing path for further development

Fierce Pharma

clinical trials

vaccine patches

Flag link:

Despite flu admissions rising, Tamiflu fill rates are on the decline

Despite flu admissions rising, Tamiflu fill rates are on the decline

Beckers Hospital Review

Flag link:

Experimental flu vaccine, developed using mRNA, seen as potential game changer

Experimental flu vaccine, developed using mRNA, seen as potential game changer

Stat

Flag link:

Despite high demand, Tamiflu drugmaker says it's on track with supply

Despite high demand, Tamiflu drugmaker says it's on track with supply

Beckers Hospital Review

Flag link:

Pediatric health groups call for national emergency to fight respiratory illnesses

Pediatric health groups call for national emergency to fight respiratory illnesses

The Hill

Flag link:

Quest broadens access to COVID-19 multiplex tests as flu cases rise

Quest broadens access to COVID-19 multiplex tests as flu cases rise

Medtech Dive

Quest Diagnostics

Flag link:

Pfizer, BioNTech start COVID-flu combination vaccine study

Pfizer, BioNTech start COVID-flu combination vaccine study

Reuters

clinical trials

Flag link:

In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK-allied mAb

In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK-allied mAb

Endpoints

Vir Biotechnology

federal contracts

Flag link:

Pages